Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 610 MSEK in 2015. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange.
The group aims to accelerate the drug discovery and development process, and to increase knowledge by providing complete solutions for Medicinal and Analytical Chemistry and Process Development. The company aims to be market leading in each of its niche areas.
The company has a strong customer base of industry and academic partners, which include the world’s top 20 pharmaceutical companies and prestigious academic institutes such as the US National Institutes of Health, the US Centers for Disease Control and Prevention and the Karolinska Institute in Sweden.
Headquartered in Uppsala, Sweden, Biotage AB also has facilities in Lund, Sweden; Charlotte, NC, USA; Cardiff, UK; Tokyo and Osaka, Japan; and Shanghai, China.
- Focus : Manufacturer
- Employees: 201-500
- Industry : Laboratory analysis / Laboratory measurement technology
Products from Biotage
News about Biotage
04-Jun-2019 | Cooperation
Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications
Biotage AB announced its strategic collaboration with Shandong Yingsheng Biotechnology Co., Ltd.. Yingsheng is mainly focused on independently researching ...
28-May-2019 | People
Tomas Blomquist: New CEO & President of Biotage
Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas Blomquist, most recently Vice President EMEA Cardimetabolic at ...
08-Dec-2017 | Finances
Biotage acquires Horizon Technology
Biotage AB has entered into an agreement to acquire all outstanding shares in the privately held company Horizon Technology, Inc. (Horizon) based in New ...
21-Apr-2010 | Technology
Biotage Awarded Patent for Flash Purification Method Development and Optimization
Biotage announced it has recently been awarded U.S. patent 7686959: Control system and Method for Flash Separation. The patented technology converts thin- ...
21-Feb-2008 | Market
Biotage AB Increases Focus on Environmental Market Segments
Biotage AB announced plans to increase its focus on growing business opportunities in the environmental analysis business. The strategy includes redeployed ...
20-Jan-2006 | Cooperation
Biotage AB Signs Two Exclusive Agreements with Reaxa
Under a first agreement between Reaxa and Biotage both companies will develop "MicroEnCat(tm)" an encapsulated palladium catalyst range optimized for use ...
13-Jan-2006 | Business
Biotage AB acquires rights to novel Evaporation system from Vapourtec, Ltd.
Biotage has acquired the exclusive distribution, production and further development rights to Vapourtecs solvent evaporation system, known as the V-10. The ...